Repros Therapeutics Incorporated
News and Blogs
Total : 7 View more »
Repros Therapeutics Inc. Shares Soar on Successful Testosterone Study; Company Reports Androxal(R)
www.biospace.com | Oct 7, 2009
Secondary hypogonadism is a deficiency state in which the male hormone testosterone goes below the normal range, even in aging men, due to inadequate stimulation of the testes by the pituitary.
http://www.biospace.com/news_story.aspx?StoryID=158395&full=1
Austin law firm files class action against Repros Therapeutics
www.bizjournals.com | Sep 8, 2009
The funding comes just after The Woodlands biopharmaceutical company said it faced possible bankruptcy unless new financing was secured as a result of the voluntary stopping of trials for its Proellex drug on Aug. 3.
http://www.bizjournals.com/houston/stories/2009/09/07/daily2.html?ana=from_rss
Repros Therapeutics Inc. Suspends Dosing of Proellex(R) and Provides Update on Financial Status
www.biospace.com | Oct 4, 2009
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics (NasdaqGM:RPRX - News) announced today that, in the interest of patient safety, it is voluntarily suspending dosing of all patients in its clinical trials of Proellex.
http://www.biospace.com/news_story.aspx?StoryID=151910&full=1
Repros Therapeutics Inc. Announces Financing - News, Search Jobs, Events
www.biospace.com | Oct 8, 2009
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics today announced that Repros has entered into a definitive agreement with institutional investors to sell 3.5 million shares of its common stock at $1.27 per share for gross proceeds of approximately $4.4 million.
http://www.biospace.com/news_story.aspx?StoryID=158521&full=1
News from Zibb.com
Total : 34 View more »
Repros Therapeutics Down 46.5% Since SmarTrend's Sell Recommendation - Zibb.com
Nov 17, 2009 (SmarTrend(R) Spotlight via COMTEX) --
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Repros Therapeutics (NASDAQ:RPRX) on October 12, 2009 at $1.42.
Since then, Repros Therapeutics has returned 46.5% as of today's recent price of $0.76. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq profit securities trial
Repros Therapeutics names new board member - Zibb.com
Nov 16, 2009 (Datamonitor via COMTEX) --
Repros Therapeutics, a developer of oral small molecule drugs, has appointed Jaye Thompson to its board of directors, and as a member of the board's audit committee.
Dr Thompson has previously assisted Repros in many of the company's clinical studies and is familiar with the company's products and programs. Dr Thompson was the president and founder of Synergos, a full service contract research organization.
Dr Thompson holds a bachelor's degree in applied mathematics from Texas A&M University and an MS and a PhD in biostatistics from the University of Texas Health Science Center in Houston.
Joseph Podolski, CEO, and a member of the board of Repros, said: "I am pleased that Jaye has agreed to serve on our board. I have worked with Jaye for over 10 years, and I believe that she will bring a significant amount of relevant expertise and insight to our company, especially in the area of clinical development of our two product candidates."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon
Tags: ceo clinical contract drugs health products research science texas university
Companies: Repros Therapeutics Inc (RPRX)
Repros Therapeutics (RPRX) Bearish Technical Alert - Trend Down 33.1% - Zibb.com
Nov 04, 2009 (SmarTrend(R) Spotlight via COMTEX) --
Repros Therapeutics (NASDAQ:RPRX) is trading 2% lower (down $0.02 to $0.95) today on volume of 208,270 shares. The stock has traded within a 52-week range of $0.65 and $13.94.
Repros Therapeutics is currently below its 50-day moving average of $1.08 and below its 200-day moving average of $5.11.
SmarTrend is bearish on shares of RPRX and our subscribers received a Downtrend alert on October 12, 2009 at $1.42, which has returned 33.1% to date.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq securities
Repros Therapeutics (RPRX) Bearish Technical Alert - Trend Down 48.4% - Zibb.com
Nov 10, 2009 (SmarTrend(R) Spotlight via COMTEX) --
Repros Therapeutics (NASDAQ:RPRX) is trading 10.2% lower (down $0.08 to $0.73) today on volume of 780,425 shares. The stock has traded within a 52-week range of $0.65 and $13.94.
Repros Therapeutics is currently below its 50-day moving average of $1.08 and below its 200-day moving average of $4.90.
SmarTrend is bearish on shares of RPRX and our subscribers received a Downtrend alert on October 12, 2009 at $1.42, which has returned 48.4% to date.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: market nasdaq securities
Web Sites
Total : 6 View more »
Repros Therapeutics
Repros Therapeutics Inc. Announces That Proellex Significantly Reduced Pain in a U.S.
Repros Therapeutics Inc. - Analyst News | newratings.com
Copyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.
http://www.newratings.com/headlines/Repros-Therapeutics-Inc-_US76028H1005.html
Repros Announces Appointment of Chief Medical Officer
THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (Nasdaq:RPRX - News; PCX:RPRX - News) today announced it has hired Dr. Andre van As, M.D., Ph.D. to serve as the Company's Chief Medical Officer and Sr. VP of Clinical and Regulatory Affairs. Dr.
American Stock Exchange News Releases - AMERICAN STOCK EXCHANGE TO TRADE OPTIONS ON REPROS
New York, September 14, 2006 - The American Stock Exchange (Amex) will launch trading in options on Friday September 15, 2006, on the following Nasdaq Stock Market listed stocks of:
Web Sites
powered by 
Total : 29 View more »
Repros Therapeutics
reprosrx.com
Livney and Partners ... 2408 Timberloch Place, B-7 The Woodlands, Texas 77380
Repros Therapeutics Incorporated | RPRX | RPRX | TheStreet.com
www.thestreet.com
Stay informed on the latest Repros Therapeutics Incorporated news. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
http://www.thestreet.com/topic/6055/repros-therapeutics-incorporated.html
RPRX - Repros Therapeutics Incorporated | RPRX Stock Quotes ...
www.thestreet.com
Get the latest RPRX - Repros Therapeutics Incorporated stock market performance data. TheStreet is the source for financial market news, trading stock, quotes, and personal finance ...
Repros Therapeutics, Incorporated - Company Profiles - Resources ...
www.portfolio.com
Find business news, business blogs, executive career advice, business travel, business culture, company & executive profiles.
http://www.portfolio.com/resources/company-profiles/Repros-Therapeutics-Incorporated-2357